CREATIVE MEDICAL TECHNOLOGY (CELZ) Stock Balance Sheet
NASDAQ:CELZ • US22529Y4089
Current stock price
2.24 USD
-0.01 (-0.44%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 7.21M | 5.94M | 3.47M | 8.32M | 10.72M | |||
| Marketable Securities | N/A | 0.00 | 6.52M | N/A | N/A | |||
| Receivables | 52.10K | N/A | N/A | 0.00 | 0.00 | |||
| Inventories | 0.00 | 2.20K | 6.60K | 10.00K | 10.00K | |||
| Other Current Assets | 138.80K | 192.70K | 277.30K | 10.42M | 3.28K | |||
| Total Current Assets | 7.40M | 6.14M | 10.27M | 18.75M | 10.74M | |||
| Non-Current Assets | ||||||||
| Intangibles | 407.20K | 530.60K | 441.00K | 440.00K | 530.00K | |||
| Other Non-Current Assets | 3.30K | 3.30K | 3.30K | 0.00 | 0.00 | |||
| Total Non-Current Assets | 410.50K | 533.80K | 444.30K | 440.00K | 530.00K | |||
| TOTAL ASSETS | 7.81M | 6.67M | 10.72M | 19.19M | 11.27M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 0.00 | 39.90K | 39.90K | 40.00K | 20.00K | |||
| Accounts Payable | 270.70K | 273.50K | 317.30K | 3.27M | 760.00K | |||
| Other Current Liabilities | 14.20K | 14.20K | 14.20K | 10.00K | 260.00K | |||
| Total Current Liabilities | 284.90K | 327.60K | 371.40K | 3.32M | 1.05M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 10.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 294.90K | 327.60K | 371.40K | 3.32M | 1.05M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -70.59M | -64.59M | -59.10M | -53.81M | -43.67M | |||
| Additional Paid In Capital | 78.11M | 70.93M | 69.71M | 69.66M | 53.88M | |||
| Minority Interest | 10.00K | N/A | N/A | N/A | N/A | |||
| Common Shares | 3.10K | 1.80K | 1.40K | 10.00K | 10.00K | |||
| Treasury Stock | -10.00K | 0.00 | -271.00K | N/A | N/A | |||
| Shares Outstanding | 3.70M | 1.75M | 1.37M | 1.41M | 630.00K | |||
| Tangible Book Value per Share | 1.92 | 3.32 | 7.21 | 10.94 | 15.38 | |||
| Total Shareholders' Equity | 7.51M | 6.34M | 10.34M | 15.86M | 10.22M | |||
| TOTAL LIABILITIES AND EQUITY | 7.81M | 6.67M | 10.72M | 19.19M | 11.27M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 25.97 | 18.73 | 27.65 | 5.65 | 10.23 | |||
| Return On Assets (ROA) | -76.77% | -82.37% | -49.34% | -52.84% | 170.45% | |||
| Return On Equity (ROE) | -79.78% | -86.63% | -51.11% | -63.93% | 187.96% | |||
All data in USD , ROIC based on taxRate of 0.21